Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -117.26M | -88.42M | -91.36M | -87.41M | -83.58M |
| Total Depreciation and Amortization | 4.28M | 4.88M | 4.57M | 4.06M | 3.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.85M | 6.98M | 6.12M | 5.86M | 6.35M |
| Change in Net Operating Assets | -4.43M | 8.20M | 13.39M | 14.85M | 13.59M |
| Cash from Operations | -78.56M | -68.35M | -67.27M | -62.64M | -60.07M |
| Capital Expenditure | -518.00K | -1.89M | -6.59M | -12.41M | -17.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.51M | 28.20M | 12.73M | -72.55M | -105.45M |
| Cash from Investing | 43.99M | 26.31M | 6.14M | -84.96M | -123.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 685.00K | 1.24M | 1.84M | 69.39M | 69.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 685.00K | 1.24M | 1.84M | 69.39M | 69.36M |
| Foreign Exchange rate Adjustments | 64.00K | -15.00K | -13.00K | -4.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.82M | -40.82M | -59.31M | -78.21M | -114.07M |